Rezolute, Inc.’s Post

View organization page for Rezolute, Inc., graphic
Rezolute, Inc.

6,275 followers

A recent letter published in NEJM Group detailed the compassionate use of our human monoclonal antibody #RZ358 in one patient for the treatment of malignant #insulinoma and refractory #hypoglycemia. Read the full piece here: https://bit.ly/47Z3eLB

Anti–Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia | NEJM

Anti–Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia | NEJM

nejm.org

Maz Riverin

1y

Great work and congrats 👏

Like
Reply
Zizi Uzezi Imatorbhebhe

CEO @ Bios Health Group | Commercial Strategy, Clinical Development Optimization, Capital Raising & Investment. Recipient PharmaVoice 100 Stand Out Leader Award.

1y

Awesome! Great work Rezolute, Inc. !

Like
Reply
See more comments

To view or add a comment, sign in

Rezolute, Inc.

6,275 followers

View Profile

Explore topics